Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)

4.37
Delayed Data
As of Sep 01
 +0.09 / +2.10%
Today’s Change
2.96
Today|||52-Week Range
9.32
-35.07%
Year-to-Date

Today’s Trading

Previous close4.28
Today’s open4.30
Day’s range4.24 - 4.39
Volume376,977
Average volume (3 months)530,388
Market cap$189.9M
Dividend yield--
Data as of 3:59pm ET, 09/01/2015

Growth & Valuation

Earnings growth (last year)-54.24%
Earnings growth (this year)+39.84%
Earnings growth (next 5 years)+46.60%
Revenue growth (last year)-82.32%
P/E ratioNM
Price/Sales57.18
Price/Book4.01

Competitors

 Today’s
change
Today’s
% change
CYNACynapsus Therapeutic...-0.01-0.06%
MRNSMarinus Pharmaceutic...+0.05+0.37%
MSLIMerus Labs Internati...-0.05-2.77%
AQXPAquinox Pharmaceutic...-0.41-2.40%
Data as of 3:59pm ET, 09/01/2015

Financials

Next reporting dateNovember 3, 2015
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$5.2M
Annual profit (last year)-$33.4M
Net profit margin-639.31%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Howard B. Rosen
CFO &
Head-Business Development
Timothy E. Morris
Corporate headquarters
Redwood City, California

Forecasts

Partner Offers